Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BB Biotech AGXSWX:BION +1.17%33 Market Cap is CHF2,873 Mil as of Aug. 10, 2026. GuruFocus rates XSWX:BION with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 1,419 Biotechnology companies, BB Biotech AG ranks better than 92.18% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BB Biotech AG's share price for the quarter that ended in Jun. 2026 was CHF48.75. BB Biotech AG's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 55 Mil. Therefore, BB Biotech AG's market cap for the quarter that ended in Jun. 2026 was CHF2,689 Mil.
BB Biotech AG's quarterly market cap
declined
from Dec. 2025 (CHF2,479 Mil) to Mar. 2026 (CHF2,451 Mil) but then
increased
from Mar. 2026 (CHF2,451 Mil) to Jun. 2026 (CHF2,689 Mil).
BB Biotech AG's annual market cap
declined
from Dec. 2023 (CHF2,345 Mil) to Dec. 2024 (CHF1,939 Mil) but then
increased
from Dec. 2024 (CHF1,939 Mil) to Dec. 2025 (CHF2,479 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BB Biotech AG's Enterprise Value for Today is CHF2,670 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
BB Biotech AG Market Cap Related Terms
BB Biotech AG Market Cap Historical Data
* Premium members only.
The historical data trend for BB Biotech AG's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:BION vs VRTX, REGN, RVMD: Market Cap Comparison
For the Biotechnology subindustry, BB Biotech AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BB Biotech AG Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BB Biotech AG's Market Cap distribution charts can be found below:
* The bar in red indicates where BB Biotech AG's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
BB Biotech AG's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BB Biotech AG (XSWX:BION) has a Market Cap of CHF2,873 Mil as of Aug. 10, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BB Biotech AG and its competitors. According to the industry distribution chart, BB Biotech AG ranks #111 out of 1419 companies in the Biotechnology industry, placing it in the top 7.8%.
Is BB Biotech AG's Market Cap too high?
BB Biotech AG's current Market Cap is CHF2,873 Mil. Based on the distribution chart, BB Biotech AG ranks #111 out of 1419 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, BB Biotech AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #111 out of 1419 companies for Market Cap. This places BB Biotech AG in the top 8% of its industry — outperforming the majority of peers. The industry median Market Cap is 116.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 116.54, based on 1,419 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BB Biotech AG and its competitors. For the Biotechnology industry, the median Market Cap is 116.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BB Biotech AG's current Market Cap is CHF2,873 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current Market Cap of CHF2,873 Mil. The current Market Cap is CHF2,873 Mil. BB Biotech AG's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current Market Cap is CHF2,873 Mil as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
33GF Score
Get the complete analysis for XSWX:BION
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:BION has been successfully added to your 
